Dermavant Sciences initiates phase III study of tapinarof for the treatment of plaque psoriasis June 3, 2019
Results of phase IIb trial of topical PAC-14028, a TRPV1 antagonist, in atopic dermatitis May 28, 2019
Proof of concept achieved for KB-103 as topical treatment for epidermolysis bullosa dystrophica May 17, 2019
Phase III study of abrocitinib in atopic dermatitis meets all coprimary and secondary endpoints May 15, 2019
RSS